Unraveling depression in Parkinson's disease

European Journal of Neurology

Volumn 15, Issue 9, 2008, Pages 885-886

  Antonini, A ^a  

^a PARKINSON INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; LEVODOPA; PRAMIPEXOLE; ROTIGOTINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

COGNITIVE DEFECT; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFICACY; EDITORIAL; PARKINSON DISEASE; PRIORITY JOURNAL; UNIFIED PARKINSON DISEASE RATING SCALE;

ANTIDEPRESSIVE AGENTS; BENZOTHIAZOLES; CLINICAL TRIALS AS TOPIC; COHORT STUDIES; DEPRESSION; DEPRESSIVE DISORDER; DOPAMINE; DOPAMINE AGONISTS; DRUG INTERACTIONS; HUMANS; MULTICENTER STUDIES AS TOPIC; PARKINSON DISEASE; QUALITY OF LIFE; SEROTONIN; SERTRALINE;

EID: 49549109857     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2008.02216.x     Document Type: Editorial

References (14)

1. Global Parkinson's Disease Survey Steering Committee. Factors impacting on quality of life in Parkinson's disease: results from an international study. Movement Disorders 2002 17 : 60 67.
2. Hughes TA, Ross HF, Mindham RH, Spokes EG. Mortality in Parkinson's disease and its association with dementia and depression. Acta Neurologica Scandinavica 2004 110 : 118 123.
3. Weintraub D, Moberg PJ, Duda JE, et al. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease. Journal of the American Geriatrics Society 2004 52 : 784 788.
4. Nuti A, Ceravolo R, Piccinni A, et al. Psychiatric comorbidity in a population of Parkinson's disease patients. European Journal of Neurology 2004 11 : 315 320.
5. Chaudhuri KR, Martinez-Martin P, Schapira AH, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Movement Disorders 2006 21 : 916 923.
6. Horstink M, Tolosa E, Bouccelli U, et al. Review of the therapeutic management of Parkinson's disease. European Journal of Neurology 2006 13 : 1186 1202.
7. Ghazi-Noori S, Chung TH, Deane KHO, Rickards H, Clarke CE. Therapies for depression in Parkinson's disease. Cochrane database of Systematic Reviews 2003 3 CD003465.
8. Richard IH, Kurlan R and the Parkinson Study Group. A survey of antidepressant drug use in Parkinson's disease. Neurology 1997 49 : 1168 1170.
9. Brandt-Christensen M, Kvist K, Nilsson FM, Andersen PK, Kessing LV. Treatment with antiparkinson and antidepressant drugs: a register-based, pharmaco-epidemiological study. Movement Disorders 2007 31 : 22.
10. Antonini A, Colosimo C, Marconi R, Morgante L, Barone P. The PRIAMO study: background, methods and recruitment. Neurological Sciences 2008 29 : 61 65.
11. Antonini A, Tesei S, Zecchinelli A, et al. Randomized study of sertraline and low-dose amitriptyline in patients with Parkinson's disease and depression: effect on quality of life. Movement Disorders 2006 21 : 1119 1122.
12. Kulisevsky J, Pagonabarraga J, Pascual-Sedano B, Gironell A, García-Sánchez C, Martínez-Corral M. Motor changes during sertraline treatment indepressed patients with Parkinson's disease. European Journal of Neurology 2008 15 : 953 959.
13. Barone P, Scarzella L, Marconi R, et al. Pramipexole versus sertraline in the treatment of depression in Parkinson's disease: a national multicenter parallel-group randomized study. Journal of Neurology 2006 253 : 601 607.
14. Poewe W, Rascol O, Quinn N, et al. Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial. Lancet Neurology 2007 6 : 513 20.